News
Census Launch: India’s first phase of Census 2026 starts April 1 with houselisting, followed by population enumeration in 2027.
In this article, a single-phase transformerless inverter for photovoltaic (PV) applications is introduced. The proposed inverter provides common ground between input and output terminals, which ...
DC offset in the input of phase-locked loops (PLLs) is a challenging problem since it will result in fundamental frequency oscillations in the estimated phase and frequency. In this paper, a ...
Eyestem has announced the completion of its phase 1 study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The company has submitted the results to the Central Drugs ...
Placebo-subtracted mean weight loss up to 8.4% at Day 36 19-day observed half-life supports once-monthly dosing as monotherapy and potential first-in-category monthly GLP-1 + Amylin combination ...
The 8.4% weight loss mark reported Monday was achieved by the 1.2 mg dose, the highest of four doses of the drug administered weekly for five weeks in a two-part Phase 1 study. Each part enrolled ...
Dr Alex Boote, product and innovation manager at ARC Building Solutions, a manufacturer of cavity fire barriers and insulation products The government recently announced its plan for Phase 1 of ...
The 2025 MLB All-Star Game in Atlanta will have a Motor City feel if the voting trends continue. But voting hasn't ended. It has only transitioned from Phase 1 to Phase 2, with Báez, Greene and ...
The randomised, phase 1 study will evaluate the safety, tolerability, and immunogenicity of the nucleoside-modified RNA (modRNA)based combination vaccine, which combines Pfizer’s quadrivalent ...
Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.
Innovent Biologics presents data from phase 1 PoC study of IBI363 to treat advanced NSCLC at 2025 ASCO San Francisco Friday, June 6, 2025, 18:00 Hrs [IST] Innovent Biologics, Inc. (Innovent), a ...
As Kanu’s trial reaches a “crucial and decisive phase,” IPOB urged all stakeholders to remain “vigilant, vocal, and committed,” adding that the leader’s spirit remains unbroken and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results